These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Key problems of chemotherapy for gynecological malignancies]. Tan XJ, Lang JH. Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):561-3. PubMed ID: 23141172 [No Abstract] [Full Text] [Related]
8. [Chemotherapy of advanced gynecological cancer and its limitation--findings in compound and multidisciplinary treatment]. Katashima S, Iwasaki M. Nihon Gan Chiryo Gakkai Shi; 1983 Apr 20; 18(3):704-15. PubMed ID: 6619636 [No Abstract] [Full Text] [Related]
9. Current dilemmas in carboplatin dosing. Ratain MJ. Clin Adv Hematol Oncol; 2011 Mar 20; 9(3):237-8. PubMed ID: 21475131 [No Abstract] [Full Text] [Related]
10. Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut). du Bois A, Pfisterer J, Burchardi N, Loibl S, Huober J, Wimberger P, Burges A, Stähle A, Jackisch C, Kölbl H, Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom, Kommission Uterus. Gynecol Oncol; 2007 Dec 20; 107(3):518-25. PubMed ID: 17910981 [Abstract] [Full Text] [Related]
16. [The role of chemotherapy in the treatment of gynecological tumours (author's transl)]. Trnka V. Cesk Gynekol; 1976 Dec 20; 41(10):713-6. PubMed ID: 1009600 [No Abstract] [Full Text] [Related]
17. [Nursing of gynecological patients treated by chemotherapy]. Xian M. Zhonghua Hu Li Za Zhi; 1985 Jun 20; 20(3):156-8. PubMed ID: 3849358 [No Abstract] [Full Text] [Related]
18. Safety and efficacy of repeated monthly carboplatin desensitization. Morgan M, Bowers DC, Gruchalla RS, Khan DA. J Allergy Clin Immunol; 2004 Oct 20; 114(4):974-5. PubMed ID: 15480344 [No Abstract] [Full Text] [Related]
19. [Clinical evaluation of calculating carboplatin dosage using Japanese equation for estimating GFR for gynecologic cancer]. Kidera Y, Nakao M, Tsubaki M, Yoshinaga M, Kajitani F, Yanae M, Sakano M, Yamazoe Y, Chiba Y, Moriyama K, Nishida S. Gan To Kagaku Ryoho; 2011 Jul 20; 38(7):1143-8. PubMed ID: 21772099 [Abstract] [Full Text] [Related]
20. [Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma]. Hosaka M, Ebina Y, Moriwaki M, Hara Y, Araki N, Todo Y, Takeda M, Watari H, Sakuragi N. Gan To Kagaku Ryoho; 2007 Sep 20; 34(9):1505-8. PubMed ID: 17876157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]